| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| Company: Fortress Biotech (subsidiary) |
| Recipient: You |
| Company: Elephas Bio |
| Recipient: You |
| Company: CurIOS Therapeutics |
| Recipient: You |
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Bristol-Myers Squibb |
| Recipient: You |
| Company: Octane Global |
| Recipient: You |
| Company: Defined Health |
| Recipient: You |
| Company: Dedham Group |
| Recipient: You |
| Company: Adept Field Solutions |
| Recipient: You |
| Company: Slingshot Insights |
| Recipient: You |
| Company: Blueprint Partnerships |
| Recipient: You |
| Company: Charles River Associates |
| Recipient: You |
| Company: Trinity Group |
| Recipient: You |
| Company: Insight Strategy |
| Recipient: You |
| Company: Schlesinger Associates |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: AVEO |
| Recipient: You |
| Company: Catenion |
| Recipient: You |
| Company: Cello Health |
| Recipient: You |
| Company: Aptitude Health |
| Recipient: You |
| Company: Abbvie |
| Recipient: You |
| Company: Targeted Oncology |
| Recipient: You |
| Company: DLA Piper |
| Recipient: You |
| Company: Merck |
| Recipient: You |
| Company: Elephas Bio |
| Recipient: You |
| Company: CurIOS Therapeutics |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Pfizer |
| Recipient: You |
| Company: Scholar Rock |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: 2nd.MD |
| Recipient: You |
| Company: Compugen |
| Recipient: You |
| Company: Link Cell Therapies |
| Recipient: You |
| Company: Scholar Rock |
| Recipient: You |
| Company: Scholar Rock |
| Recipient: You |
| Company: Neomorph |
| Recipient: You |
| Company: Nimbus Therapeutics |
| Recipient: You |
| Company: Daiichi Sankyo |
| Recipient: You |
| Company: Scholar Rock |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: GU Oncology Now |
| Recipient: You |
| Company: SignifyMD |
| Recipient: You |
| Company: Caris Life Sciences |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Exelixis |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Bristol-Myers Squibb |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|